Ledipasvir
Back to searchMolecule Structure
Scientific Name
Ledipasvir
Description of the Drug
Ledipasvir is a direct-acting antiviral agent used to treat specific hepatitis C virus (HCV) infections in combination with other antiviral agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09027
http://www.drugbank.ca/drugs/DB09027
Brand Name(s)
Not Available
Company Owner(s)
Gilead Sciences Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Nonstructural protein 5A | SINGLE PROTEIN | INHIBITOR | CHEMBL3307224 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2706494 |
PharmGKB | PA166128166 |
DrugBank | DB09027 |
PubChem | 67505836 |
LINCS | LSM-45925 |
Nikkaji | J3.451.453D |
EPA CompTox Dashboard | DTXSID90154829 |
DrugCentral | 4899 |
ChemicalBook | CB52666650 |
Guide to Pharmacology | 11271 |
rxnorm | LEDIPASVIR |
ChEBI | 85089 |
ZINC | ZINC000150338819 |